Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_assertion type Assertion NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_head.
- NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_assertion description "[These results suggest that FGF21 could be a novel and attractive drug candidate for the treatment of cardiovascular disease, obesity and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_provenance.
- NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_assertion evidence source_evidence_literature NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_provenance.
- NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_assertion SIO_000772 19337957 NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_provenance.
- NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_assertion wasDerivedFrom befree-2016 NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_provenance.
- NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_assertion wasGeneratedBy ECO_0000203 NP729855.RAQO9FBLWGZTVxhY-VGym7lYUB5J_ombPTe8DfZDf4P58130_provenance.